Fennec Pharmaceuticals Inc. (FENC) vs MapLight Therapeutics, Inc. (MPLT)
A side-by-side comparison of Fennec Pharmaceuticals Inc. and MapLight Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FENC
Fennec Pharmaceuticals Inc.
$10.35HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
MPLT
MapLight Therapeutics, Inc.
$9.69HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — FENC vs MPLT
growth of $100 · dividends reinvested · last 1yFENC +18.5% (+18.5%/yr)MPLT -49.4% (-49.4%/yr)FENC compounded faster over this window
FENC MPLT
FENC vs MPLT: by the numbers
- •MPLT is the larger company ($411M vs $360M market cap).
- •Both run net losses; MPLT's is the smaller (0.00% vs -5.49% net margin).
Metrics side by side
Valuation
| Metric | FENC | MPLT |
|---|---|---|
| Forward P/E | 36.53 | N/A |
| P/S ratio | 6.07 | N/A |
| P/B ratio | 8.47 | 1.18 |
Profitability
| Metric | FENC | MPLT |
|---|---|---|
| Gross margin | 93.73% | 0.00% |
| Operating margin | -14.22% | 0.00% |
| Net margin | -5.49% | 0.00% |
| ROE | -7.66% | -65.99% |
| ROIC | -1.84% | -69.35% |
Growth (annualized)
| Metric | FENC | MPLT |
|---|---|---|
| Revenue CAGR (5Y) | 222.46% | N/A |
| Total return CAGR (5Y) | 2.45% | N/A |
Go deeper
Dig into the metrics
Fennec Pharmaceuticals ROEMapLight Therapeutics ROEFennec Pharmaceuticals operating marginMapLight Therapeutics operating marginFennec Pharmaceuticals revenue growthMapLight Therapeutics revenue growthFennec Pharmaceuticals free cash flowMapLight Therapeutics free cash flow
Fennec Pharmaceuticals & MapLight Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.